Blog
7 results
Unravelling the complexity of cancer genomics and predisposition: nanopore sequencing and the potential for personalised care | Oxford Nanopore Technologies
- Adaptive sampling
- Cancer research
- Clinical research
- Human genomics
- Structural variation
- Gene fusions
- Methylation
- DNA
- Targeted
- Whole genome
October 17 2024
Science unlocked: publication picks from September 2024 | Oxford Nanopore Technologies
- Adaptive sampling
- AMR
- Cancer research
- Clinical research
- Epigenetics
- Human genomics
- Infectious disease
- Methylation
- Microbiology
- MinION
- Phasing
- rRNA
- Structural variation
- Targeted
- Variant calling
October 2 2024
Science unlocked: publication picks from October 2024 | Oxford Nanopore Technologies
- Adaptive sampling
- Human genomics
- Single cell
- Chromatin conformation
- Methylation
- Animal
- Variant calling
- Data storage
- Epigenetics
- Cancer research
- Targeted
- Structural variation
- Infectious disease
- Plant
- PromethION
November 5 2024
Rapid identification of MSK-IMPACT cancer variants with real-time targeted nanopore sequencing | Oxford Nanopore Technologies | Oxford Nanopore Technologies
- Adaptive sampling
- Cancer research
- Targeted
- SNVs
- Structural variation
- PromethION
- Human genomics
- Clinical research
- DNA
- Variant calling
- EPI2ME
November 28 2024
London Calling 2024 opens with a day of masterclasses delivering everything you need to know for sample-to-answer nanopore sequencing
- Adaptive sampling
- 16S
- Amplicons
- AMR
- Assembly
- Basecalling
- Bacteria
- Bioinformatics
- Cancer research
- cDNA
- Clinical research
- DNA
- Direct analysis
- EPI2ME
- Epigenetics
- Extraction
- Human genomics
- Identification
- Infectious disease
- Kits
- Masterclass
- Library prep
- London Calling
- Methylation
- Metagenomics
- Microbiology
- MinION
- MinKNOW
- P2
- PromethION
- RNA
- Sample prep
- Scalable
- Single cell
- Variant calling
- Workflow
May 21 2024
Lessons from AACR 2024 | Oxford Nanopore Technologies
- Adaptive sampling
- Cancer research
- Clinical research
- Epigenetics
- Oncology
April 16 2024